本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioRestorative Therapies, Inc.

1.78
+0.02001.14%
盘后1.800.0200+1.12%16:00 EDT
成交量:1.19万
成交额:2.14万
市值:1,335.85万
市盈率:-1.54
高:1.81
开:1.79
低:1.77
收:1.76
数据加载中...
2024/04/03

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2023/11/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/16

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/13

重要事件披露

Form 8-K - Current report
2023/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/14

重要事件披露

8-K - Current report
2023/04/06

重要事件披露

8-K - Current report
2023/03/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]